Article
Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2008
Yu Dianke, Zhang Xuemei, Liu Ju, Yuan Peng, Tan Wen, Guo Yongli, Sun Tong, Zhao Dan, Yang Ming, Liu Junniao, Xu Binghe, Lin Dongxin
Abstract excerpt
PURPOSE: The excision repair cross-complementation group 1 (ERCC1) plays a pivotal role in DNA repair and has been linked to protection against carcinogenesis and resistance to platinum-based anticancer drugs. We tested whether genetic variants in the ERCC1 gene are associated with susceptibility...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
